RE104 for generalized anxiety symptoms
About this title
Read the official source — NCT07489651This study evaluates the safety and effectiveness of RE104 for Injection for people with anxiety.
Understand this study
What is this study about?
This study evaluates the safety and effectiveness of RE104 for Injection for people with anxiety.
Who could participate?
This study is for people with anxiety. Listed age limits: 18 years to 74 years. Other eligibility criteria apply.
- Listed locations
- Birmingham and 27 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 160
- Sponsor
- Reunion Neuroscience Inc
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 74 Years
- Official registry ID
- NCT07489651
- Official title
Show the full official title
A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of RE104 for Injection in the Treatment of Generalized Anxiety Disorder
Recruitment & locations
Birmingham · Gilbert · Little Rock
24 more locations
- Garden Grove
- La Jolla
- San Francisco
- Santa Monica
- Lauderhill
- Tampa
- Atlanta
- Decatur
- Norcross
- Savannah
- Chicago
- Novi
- Saint Charles
- Albuquerque
- New York
- Chapel Hill
- North Canton
- Portland
- Philadelphia
- West Chester
- Austin
- Plano
- Draper
- Orem
Interested in joining this study?
Questions about this study
What is this study about?
This study evaluates the safety and effectiveness of RE104 for Injection for people with anxiety.
Who is behind this study?
The study sponsor is Reunion Neuroscience Inc.
Does this study involve medication?
Yes. The study involves medication, including RE104 for Injection and Placebo.
Who can participate?
This study is for people with anxiety. Listed age limits: 18 years to 74 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as recruiting.
